TY - JOUR
T1 - Carbosilane dendrimers
T2 - Drug and gene delivery applications
AU - Rabiee, Navid
AU - Ahmadvand, Shokooh
AU - Ahmadi, Sepideh
AU - Fatahi, Yousef
AU - Dinarvand, Rassoul
AU - Bagherzadeh, Mojtaba
AU - Rabiee, Mohammad
AU - Tahriri, Mohammadreza
AU - Tayebi, Lobat
AU - Hamblin, Michael R.
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/10
Y1 - 2020/10
N2 - Carbosilane dendrimers are a particular type of dendrimer structure that has been used as delivery vehicles for drugs and nucleic acids. They have a defined structure according to their generation number, and their terminal groups can be rendered cationic or anionic. The cationic charges can address the limitation of electrostatic repulsion between the negatively charged phosphate groups of nucleic acids and negatively charged cell membranes. Specific drugs can be loaded into the central part of the dendrimer or attached at the exterior, and the overall positive charge may improve the efficacy of anti-inflammatory drugs. One promising feature of dendrimers is their non-toxicity both in vitro and in vivo up to therapeutic concentrations. Carbosilane dendrimers display good biocompatibility and can be used for anti-HIV, anti-viral, and anti-inflammatory applications, as well as for delivery of nucleic acids for anti-cancer therapy.
AB - Carbosilane dendrimers are a particular type of dendrimer structure that has been used as delivery vehicles for drugs and nucleic acids. They have a defined structure according to their generation number, and their terminal groups can be rendered cationic or anionic. The cationic charges can address the limitation of electrostatic repulsion between the negatively charged phosphate groups of nucleic acids and negatively charged cell membranes. Specific drugs can be loaded into the central part of the dendrimer or attached at the exterior, and the overall positive charge may improve the efficacy of anti-inflammatory drugs. One promising feature of dendrimers is their non-toxicity both in vitro and in vivo up to therapeutic concentrations. Carbosilane dendrimers display good biocompatibility and can be used for anti-HIV, anti-viral, and anti-inflammatory applications, as well as for delivery of nucleic acids for anti-cancer therapy.
KW - Carbosilane dendrimers
KW - Drug delivery
KW - Gene delivery
KW - Immunotherapy
KW - Nanomedicine
KW - Topical antivirals
UR - http://www.scopus.com/inward/record.url?scp=85087695174&partnerID=8YFLogxK
U2 - 10.1016/j.jddst.2020.101879
DO - 10.1016/j.jddst.2020.101879
M3 - Review article
AN - SCOPUS:85087695174
SN - 1773-2247
VL - 59
JO - Journal of Drug Delivery Science and Technology
JF - Journal of Drug Delivery Science and Technology
M1 - 101879
ER -